Evidence map›Paper›PMID 39572081›Full record

ReviewInternational journal of dermatology2025

Hair loss in athletic testosterone use in males: a narrative review.

Weeratian Tawanwongsri, Deesha D Desai, Ambika Nohria, Jerry Shapiro, Kristen I Lo Sicco

Abstract readReview
In one paragraph

Review in International journal of dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Weeratian TawanwongsriSchool of Medicine, Walailak University, Thailand.
Deesha D DesaiThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.ORCID https://orcid.org/0000-0003-0156-9912
Ambika NohriaThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.ORCID https://orcid.org/0009-0001-8914-0637
Jerry ShapiroThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.
Kristen I Lo SiccoThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Performance-enhancing drugs, such as testosterone, are used by athletes and youth to increase muscle growth and strength, particularly among males. However, these therapies potentially pose health risks, including liver toxicity, gynecomastia, and hair loss. Testosterone use is rising for performance enhancement, physical appearance, and resistance training, but there remains an absence of standardized guidelines for safe dosages. This study examines the relationship between testosterone use and hair health in males, aiming to develop guidelines for safe, responsible testosterone use. Understanding treatment outcomes in this context is crucial for informed healthcare.

Indexed as

AlopeciaDoping in SportsPerformance-Enhancing SubstancesTestosteroneAthletesGynecomastiaHumansMalePerformance-Enhancing SubstancesTestosteroneAASalopeciaathleteshair losstestosterone

Identifiers

PMID39572081
PMCPMC11931090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.